Penny Stock News: Why This Stock’s 28% Run Will Continue
December 05, 2014 at 13:36 PM EST
Shares of drug companies developing Ebola treatments have at turns soared and tanked over the past couple months amid speculation and hype. But other companies not chasing after a treatment for the disease have also attracted interest amid the worst Ebola outbreak in history. One such company is Alpha Pro Tech (NYSEMKT: APT), which made penny stock news in October when shares soared to an all-time high of $10.73. Here's a look at why APT is more than just an Ebola stock... The post Penny Stock News: Why This Stock’s 28% Run Will Continue appeared first on Money Morning - Only the News You Can Profit From .